Navigation Links
Skinvisible Patent Granted for Japan
Date:3/11/2009

- - - Patent Protection Expands for Dermatology Products with Invisicare

LAS VEGAS, March 11 /PRNewswire-FirstCall/ -- Skinvisible, Inc. (OTC Bulletin Board: SKVI) (Website: www.skinvisible.com), is pleased to announce that it has been granted a comprehensive patent in Japan for Invisicare, a product-enhancing polymer delivery system for topical dermatology products. The patent protects Invisicare in the areas of 'Topical Composition,' 'Topical Composition Precursor,' and 'Methods for Manufacturing and Using.'

(Logo: http://www.newscom.com/cgi-bin/prnh/20030416/LAW068LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20040503/INVISICARELOGO)

Skinvisible's strong intellectual property protection is often the key catalyst for a company to license products formulated with Invisicare. Skinvisible's patents provide a guaranteed period of market exclusivity to licensees. Along with developing its own formulations, Skinvisible's research and development team works directly with companies offering life cycle management for their products coming off patent. Additionally, Invisicare offers unique attributes to topical products including the ability to hold active ingredients on the skin for extended periods of time and providing a controlled, fast or slow release of the active ingredient.

"Skinvisible continues to invest into patent protection for Invisicare and its unique characteristics," said Mr. Terry Howlett, President and CEO of Skinvisible. "The strength of our patents is paramount in the success of our product licensing strategy as pharmaceutical companies worldwide battle strong competition for their own products coming off patent. Along with a new patent, Invisicare provides an exciting new marketing story for companies to utilize."

In addition to this new patent approval for Japan, Skinvisible holds patent protection in the United States, Australia and India and has numerous US and international product patents pending.

About Invisicare

Invisicare is Skinvisible's patented polymer delivery system that offers life-cycle management and unique enhancements for topically delivered products. It is a combination of hydrophilic and hydrophobic polymers that hold active ingredients on the skin for extended periods of time resisting both wash off and perspiration. Invisicare can control the release of actives, reduce irritation and can eliminate some costly manufacturing processes. It is non-occlusive and allows for normal skin respiration while protecting against environmental irritants. www.invisicare.com

About Skinvisible Pharmaceuticals, Inc.

Skinvisible Pharmaceuticals is a research-and-development company whose primary business objective is to license its proprietary formulations with Invisicare to pharmaceutical and cosmeceutical companies as well as assisting companies in enhancing their existing skin care products. Skinvisible receives a combination of research and development fees, upfront license fees, and ongoing royalties for the life of the Invisicare patent. Skinvisible's value also lies in its ability to continually generate new IP on dermatology and medical products formulated with Invisicare. www.skinvisible.com

Forward-Looking Statements: This press release contains 'forward looking' statements within the meaning of Section 21A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbors created thereby. Such statements involve certain risks and uncertainties associated with an emerging company. Actual results could differ materially from those projected in the forward looking statements as a result of risk factors discussed in Skinvisible, Inc. reports on file with the U.S. Securities and Exchange Commission (including, but not limited to, a report on Form 10Q for the quarter ending September 30, 2008).

    Corporate Contact:
    Doreen McMorran, VP Business Development
    Skinvisible Pharmaceuticals, Inc.
    Phone: 702-433-7154
    Email: info@skinvisible.com


'/>"/>
SOURCE Skinvisible, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Skinvisible Signs Dermatology Agreement With RHEI Pharmaceuticals
2. Skinvisible and Cambrex Enter Into Agreement to Develop Acne Products
3. Skinvisible Appoints Dr. Geert Cauwenbergh to Its International Advisory Board
4. Skinvisible Offers 8 Hour Photostablity for Parsol 1789
5. Skinvisible Appoints New Vice President of Business Development & Marketing
6. Skinvisible Signs Licensing Agreement for Two Acne Formulations
7. Skinvisible Appoints New Board Member
8. Skinvisible Announces Licensing Agreement for Adapalene
9. Skinvisible Signs Marketing Agreement for India
10. Skinvisible Appoints Dr. George Korkos to Its Advisory Board
11. Skinvisible to Present at Merriman Curhan Ford & Co.s Investor Summit 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... While it’s often important to take certain ... inventor from Austin, Texas, has identified a solution. , She developed a prototype for ... lighting. As such, it eliminates the need to turn on a light when taking ...
(Date:10/13/2017)... ... October 13, 2017 , ... Southern ... and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice Frueh, ... cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU School ...
(Date:10/13/2017)... ... 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills is proud ... and unique items from across the nation, this holiday-themed event will raise funds and ... the VNA. The boutique will be open Saturday, November 4 (10:00 a.m. – ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented ... the lowdown on sciatica in a new episode of "Success Files," which is ... events and innovation and investigates each subject in-depth with passion and integrity. , ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), an ... showcase a range of technology and learning solutions at the 68th Annual American ... to be held October 14–18, 2017 at the Mandalay Bay Resort in Las ...
Breaking Medicine News(10 mins):
(Date:10/7/2017)... 2017   Provista, a proven leader in ... in purchasing power, today announced a new resource area ... Newsroom is the online home for case studies, ... bios, news releases, slideshows and events. ... of resources at their fingertips, viewers can also watch ...
(Date:10/2/2017)... 2017 Diplomat Pharmacy, Inc. (NYSE: ... Consulting, LLC , and named its founder as Diplomat,s ... Tennessee , will operate under Diplomat ... service offerings for health care partners to include IT ... "In an interoperable world, technology delivers comprehensive ...
(Date:9/28/2017)... CHICAGO , Sept. 28, 2017 Hill-Rom ... quarter 2017 earnings conference call and webcast on Friday, ... 8:00 a.m. (EDT) and ending at approximately 8:30 a.m. ... to discussing the company,s 2017 financial performance and guidance ... growth opportunities, initiatives to enhance operational performance, and long-range ...
Breaking Medicine Technology: